Status | Study |
Recruiting |
Study Name: Adaptive Radiotherapy for Head and Neck Cancer Condition: Head and Neck Cancer Paranasal Sinus Cancer Oropharynx Can Date: 2017-03-15 Interventions: Radiation: Adaptive Radiotherapy ART involved modification of the radiation treatment plan during treatm |
Not yet recruiting |
Study Name: Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer Condition: Stage 0 Nasopharyngeal Carcinoma Stage 0 Paranasal Sinus Cancer Date: 2017-02-06 Interventions: Other: Physiologic Testing Und |
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
Suspended |
Study Name: Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Salivary Gland S Date: 2014-08-21 Interventions: Other: Cytology specimen Corre |
Active, not recruiting |
Study Name: Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Recurrent Metast Date: 2014-01-10 Interventions: Drug: sorafenib tosylate Given |
Recruiting |
Study Name: Integrated Cancer Repository for Cancer Research Condition: Pancreatic Cancer Thyroid Cancer Lung Cancer Date: 2013-12-02 |
Recruiting |
Study Name: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer Condition: Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Date: 2013-04-19 Interventions: Drug: carboplatin Given IV |
Active, not recruiting |
Study Name: PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Recurrent Metast Date: 2013-03-20 Interventions: Drug: PI3K inhibitor BKM120 Gi |
Withdrawn |
Study Name: Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy Condition: Mucositis Recurrent Squamous Cell Carcinoma of the Hypopharynx Date: 2012-11-13 Interventions: Drug: entolimod Given SC |
Terminated |
Study Name: Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy Condition: Chemotherapeutic Agent Toxicity Mucositis Radiation Toxici Date: 2012-09-05 Interventions: Dietary Supplement: selenomethionine |